1 Welsing PM, "The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis : a longitudinal analysis" 50 : 2082-2093, 2004
2 Murray E, "Systematic review and network meta-analysis : effect of biologics on radiographic progression in rheumatoid arthritis" 7 : 959-974, 2018
3 Mikuls TR, "Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis" 38 : 2509-2516, 2011
4 Anderson J, "Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice" 64 : 640-647, 2012
5 Smolen JS, "Rheumatoid arthritis" 4 : 18001-, 2018
6 Lillegraven S, "Remission and radiographic outcome in rheumatoid arthritis : application of the 2011 ACR/EULAR remission criteria in an observational cohort" 71 : 681-686, 2012
7 Wick MC, "Relationship between inflammation and joint destruction in early rheumatoid arthritis : a mathematical description" 63 : 848-852, 2004
8 Navarro-Compán V, "Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review" 54 : 994-1007, 2015
9 van der Heijde D, "Radiographic progression in rheumatoid arthritis:does it reflect outcome? Does it reflect treatment?" 60 (60): iii47-iii50, 2001
10 Park YJ, "Radiographic progression in clinical trials in rheumatoid arthritis : a systemic literature review of trials performed by industry" 6 : e001277-, 2020
1 Welsing PM, "The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis : a longitudinal analysis" 50 : 2082-2093, 2004
2 Murray E, "Systematic review and network meta-analysis : effect of biologics on radiographic progression in rheumatoid arthritis" 7 : 959-974, 2018
3 Mikuls TR, "Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis" 38 : 2509-2516, 2011
4 Anderson J, "Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice" 64 : 640-647, 2012
5 Smolen JS, "Rheumatoid arthritis" 4 : 18001-, 2018
6 Lillegraven S, "Remission and radiographic outcome in rheumatoid arthritis : application of the 2011 ACR/EULAR remission criteria in an observational cohort" 71 : 681-686, 2012
7 Wick MC, "Relationship between inflammation and joint destruction in early rheumatoid arthritis : a mathematical description" 63 : 848-852, 2004
8 Navarro-Compán V, "Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review" 54 : 994-1007, 2015
9 van der Heijde D, "Radiographic progression in rheumatoid arthritis:does it reflect outcome? Does it reflect treatment?" 60 (60): iii47-iii50, 2001
10 Park YJ, "Radiographic progression in clinical trials in rheumatoid arthritis : a systemic literature review of trials performed by industry" 6 : e001277-, 2020
11 Ten Klooster PM, "Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm : real-world data from the Dutch Rheumatoid Arthritis Monitoring(DREAM)registry" 21 : 237-, 2019
12 Gossec L, "Prognostic factors for remission in early rheumatoid arthritis : a multiparameter prospective study" 63 : 675-680, 2004
13 Forslind K, "Prediction of radiological outcome in early rheumatoid arthritis in clinical practice : role of antibodies to citrullinated peptides(anti-CCP)" 63 : 1090-1095, 2004
14 Nishimura K, "Meta-analysis : diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis" 146 : 797-808, 2007
15 SchiffMH, "Integrated safety in tocilizumab clinical trials" 13 : R141-, 2011
16 박윤정 ; 유승아 ; 황대희 ; 조철수 ; 김완욱, "Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis" 생화학분자생물학회 48 : 1-8, 2016
17 van der Heijde D, "How to read radiographs according to the Sharp/van der Heijde method" 27 : 261-263, 2000
18 Listing J, "HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group" 27 : 2100-2109, 2000
19 김형영 ; 성윤경, "Epidemiology of Rheumatoid Arthritis in Korea" 대한류마티스학회 28 (28): 60-67, 2021
20 Yoon-Jeong Oh ; Bumhee Park ; 문기원, "Effect of Drug Adherence on Treatment Outcome in Rheumatoid Arthritis" 대한류마티스학회 26 (26): 264-272, 2019
21 Smolen JS, "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological diseasemodifying antirheumatic drugs : 2019 update" 79 : 685-699, 2020
22 Landewé R, "Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate : results from the trial of etanercept and methotrexate with radiographic and patient outcomes" 54 : 3119-3125, 2006
23 Aletaha D, "Diagnosis and management of rheumatoid arthritis : a review" 320 : 1360-1372, 2018
24 Landewé RB, "COBRA combination therapy in patients with early rheumatoid arthritis : long-term structural benefits of a brief intervention" 46 : 347-356, 2002
25 Matthews JN, "Analysis of serial measurements in medical research" 300 : 230-235, 1990
26 Brown AK, "An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis" 58 : 2958-2967, 2008
27 Singh JA, "2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis" 68 : 1-26, 2016
28 Aletaha D, "2010 Rheumatoid arthritis classification criteria : an American College of Rheumatology/European League Against Rheumatism collaborative initiative" 62 : 2569-2581, 2010